';

On the 1st of September, the Mercurna team welcomed a new member: Annemijn Grol.

Annemijn is a Master student at HAN University of Applied Sciences and joined Mercurna to learn more about translational science, nanomedicine and messenger RNA. Over the course of her 2-year project, which includes her Master thesis, she will explore novel indications for mRNA medicines and contribute to target selection, in vitro and possibly in vivo target validation.

Mercurna